Leogard Pharmaceuticals Private Limited
About Leogard Pharmaceuticals Private Limited
Data last updated:
Leogard Pharmaceuticals Private Limited is a private limited company based in Kalyan, Maharashtra, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 11 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33100MH2018PTC307828. Its GSTIN is 27AADCL5794Q1ZK (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rita Devi and Awadheshkumar Mahadeo Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hari Vijay Lawns Bldg No 1 Shop No.7 MIDC Road, Kanchangaon Dombivali East Kalyan, Maharashtra, India – 421201.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.77 Cr, a decline of 37% compared to the previous year. For the same year it recorded a net profit of ₹3.91 Lakh (net margin 2.2%) and EBITDA of ₹5.03 Lakh (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 9% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHari Vijay Lawns Bldg No 1 Shop No.7 MIDC Road, Kanchangaon Dombivali East Kalyan, Maharashtra, India – 421201
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Leogard Pharmaceuticals Private Limited
The main business activity of Leogard Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Leogard Pharmaceuticals Private Limited FY 2025 filings available
Leogard Pharmaceuticals Private Limited reported revenue of ₹1.77 Cr (down 37% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Leogard Pharmaceuticals Private Limited
Revenue fell 37% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Leogard Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5.03 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.91 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Leogard Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Leogard Pharmaceuticals are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Leogard Pharmaceuticals Private Limited
Leogard Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs, Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| I.Q. Med Healthcare Private Limited | ₹1.78 Cr (FY 2020) | •••• | •••• | -55.0% | •••• | New Delhi, Delhi, India |
| Nova Biopharma Private Limited | ₹1.78 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Jodhpur, Rajasthan, India |
| Cavin Pharmaceuticals Private Limited | ₹1.77 Cr (FY 2024) | •••• | •••• | 0.0% | •••• | Indore, Madhya Pradesh, India |
| Aman Health Ways Diagnostics Private Limited | ₹1.77 Cr (FY 2025) | •••• | •••• | -55.0% | •••• | New Delhi, Delhi, India |
| Iheartvision Medicare Private Limited | ₹1.77 Cr (FY 2025) | •••• | •••• | 686.0% | •••• | Bhubaneswar, Odisha, India |
| Leogard Pharmaceuticals Private Limited this company | ₹1.77 Cr (FY 2025) | •••• | •••• | -37.0% | •••• | Kalyan, Maharashtra, India |
| Anmed Healthcare Private Limited | ₹1.77 Cr (FY 2025) | •••• | •••• | -18.0% | •••• | New Delhi, Delhi, India |
| Ontime Globe Kyarrier Private Limited | ₹1.77 Cr (FY 2021) | •••• | •••• | 12018.0% | •••• | Pune, Maharashtra, India |
| Xtreme Laboratories Private Limited | ₹1.77 Cr (FY 2024) | •••• | •••• | 18.0% | •••• | Rajkot, Gujarat, India |
| Velox Biologics Private Limited | ₹1.77 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Chandigarh, India |
| Evelyn Pharmaceuticals Private Limited | ₹1.77 Cr (FY 2025) | •••• | •••• | -29.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Leogard Pharmaceuticals by revenue in the Healthcare industry (Diagnostics and Pathology Labs, Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Leogard Pharmaceuticals Private Limited
Leogard Pharmaceuticals Private Limited is audited by HR JAIN & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| HR JAIN & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Leogard Pharmaceuticals Private Limited
Leogard Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rita Devi | Director | 01 Feb 2024 | 2 Years 8 Months | Current |
| Awadheshkumar Mahadeo Tiwari | Director | 11 Apr 2018 | 8 Years 5 Months | Current |
Ownership and Shareholding of Leogard Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Leogard Pharmaceuticals Private Limited
Leogard Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Leogard Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Leogard Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Leogard Pharmaceuticals Private Limited
Leogard Pharmaceuticals Private Limited has 6 board changes on record since 2018: 2 appointments and 4 cessations. The latest: Rita Devi ceased to be Additional Director on 29 Sep 2024.
Credit Ratings, Litigation & Regulatory Alerts for Leogard Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Leogard Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Leogard Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Leogard Pharmaceuticals Private Limited
Leogard Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCL5794Q1ZK | Maharashtra | Active | 01 Nov 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Leogard Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Leogard Pharmaceuticals Private Limited
Leogard Pharmaceuticals is an active private limited company based in Kalyan, Maharashtra, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 11 April 2018 (8+ years old) and is registered under CIN U33100MH2018PTC307828.
Leogard Pharmaceuticals reported revenue of ₹1.77 Cr for FY 2025 (down 37% YoY).
Leogard Pharmaceuticals has 2 current directors:
- Rita Devi - Director
- Awadheshkumar Mahadeo Tiwari - Director
Leogard Pharmaceuticals reported a net profit of ₹3.91 Lakh (net margin 2.2%) and EBITDA of ₹5.03 Lakh (EBITDA margin 2.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Leogard Pharmaceuticals is 1% over three years and 9% over five years. In the latest year (FY 2025) revenue fell 37%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Leogard Pharmaceuticals is 27AADCL5794Q1ZK, registered in Maharashtra.
The CIN (Corporate Identification Number) of Leogard Pharmaceuticals is U33100MH2018PTC307828. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Leogard Pharmaceuticals was incorporated on 11 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Leogard Pharmaceuticals by revenue are I.Q. Med Healthcare Private Limited, Nova Biopharma Private Limited, Cavin Pharmaceuticals Private Limited, Aman Health Ways Diagnostics Private Limited, Iheartvision Medicare Private Limited and 5 more, all in the Healthcare industry (Diagnostics and Pathology Labs, Formulations, Pharmaceuticals).
Rita Devi ceased to be Additional Director on 29 Sep 2024. Rita Devi was appointed as Director on 01 Feb 2024. Subodh Kashiram Sawant ceased to be Additional Director on 26 Dec 2020. Leogard Pharmaceuticals has 6 board changes on record in total.
The registered office of Leogard Pharmaceuticals is at Hari Vijay Lawns Bldg No 1 Shop No.7 MIDC Road, Kanchangaon Dombivali East Kalyan, Maharashtra, India – 421201.